Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

被引：0

作者：

Zhang, Yi ^{[1
]}

Zhou, Hu ^{[2
]}

Suo, Shanshan ^{[1
]}

Zhuang, Junling ^{[3
]}

Yang, Linhua ^{[4
]}

He, Aili ^{[5
]}

Liu, Qingchi ^{[6
]}

Du, Xin ^{[7
]}

Gao, Sujun ^{[8
]}

Li, Yarong ^{[9
]}

Li, Yan ^{[10
]}

Chen, Yuqing ^{[11
]}

Wu, Wen ^{[12
]}

Zhu, Huanling ^{[13
]}

He, Guangsheng ^{[14
]}

Hong, Mei ^{[15
]}

Jiang, Qian ^{[16
]}

Jiang, Zhongxing ^{[17
]}

Jing, Hongmei ^{[18
]}

Wang, Jishi ^{[19
]}

Xu, Na ^{[20
]}

Yue, Lingling ^{[21
]}

Zheng, Cuiping ^{[22
]}

Zhou, Zeping ^{[23
]}

Jin, Chenghao ^{[24
]}

Li, Xin ^{[25
]}

Liu, Lin ^{[26
]}

Xu, Yajing ^{[27
]}

Wu, Dengshu ^{[28
]}

Zhang, Feng ^{[29
]}

Zhang, Jin ^{[30
]}

Xiao, Zhijian ^{[31
]}

Jin, Jie ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China

[2] Henan Prov Hematol Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China

[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China

[4] Second Hosp Shanxi Med Univ, Neurosurg, Taiyuan, Peoples R China

[5] Xi An Jiao Tong Univ, Dept Neurol, Affiliated Hosp 2, Xian, Peoples R China

[6] Hebei Med Univ, Hosp 1, Shijiazhuang, Peoples R China

[7] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Hematol, Guangzhou, Peoples R China

[8] First Hosp Jilin Univ, Dept Hematol, Changchun, Peoples R China

[9] Second Hosp Jilin Univ, Dept Hematol & Oncol, Changchun, Peoples R China

[10] China Med Univ, Affiliated Hosp 1, Dept Hematopathol, Shenyang, Peoples R China

[11] Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China

[12] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom,Ruijin Hosp,Sch Med, Shanghai, Peoples R China

[13] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China

[14] Nanjing Med Univ, Key Lab Hematol, Jiangsu Prov Hosp, Collaborat Innovat Ctr Canc Personalize,Affiliated, Nanjing, Peoples R China

[15] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[16] Peking Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Peoples Hosp, Beijing, Peoples R China

[17] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[18] Peking Univ Third Hosp, Beijing, Peoples R China

[19] GuiZhou Med Univ, Dept Hematol, Affiliated Hosp, Guiyang City, Peoples R China

[20] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China

[21] Lanzhou Univ Second Hosp, Dept Hematol & Oncol, Lanzhou, Peoples R China

[22] Wenzhou Cent Hosp, Dept Oncol 2, Wenzhou, Peoples R China

[23] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China

[24] Jiangxi Prov Peoples Hosp, Nanchang, Peoples R China

[25] Cent South Univ, Third Xiangya Hosp, Dept Hematol, Changsha, Peoples R China

[26] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China

[27] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[28] Cent South Univ, Xiangya Hosp, Dept Hematol, Changsha, Peoples R China

[29] Bengbu Med Coll, Affiliated Hosp 1, Dept Hematol, Bengbu, Peoples R China

[30] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Hematol, Hangzhou, Peoples R China

[31] Chinese Acad Med Sci & Peking Union Med Coll, MDS & MPN Ctr, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-202790

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3165 / 3166

页数：2